Information agency Credinform has prepared the ranking of the largest pharmaceutical companies and medicine products manufacturers in Russia on product profitability ratio. Companies having the largest annual revenue in the industry (TOP-10) for the last available in the Statistical register period (2015 and 2014) were taken for the ranking. Further they were ranked on the product profitability value (Table 1).

Product profitability is calculated as a ratio of profit on sales to operational expenses. In the whole, the profitability reflects the production efficiency. The analysis of product profitability allows making a conclusion on release usefulness of various products. There aren’t any recommended values for this group, due to the fact that they differ greatly depending on industry.

Taking into account both the current situation in the economy in whole and in industries, the experts of the Information agency Credinformworked out and implemented in the Information and Analytical system Globas-i the calculation of the practical importance of financial ratios which may be considered standard for the specific industry. The practical importance of product profitability for pharmaceutical companies amounts to more than 21,9%.

In order to get the full and fair picture of the company’s financial situation, it is necessary to pay attention not only to compatibility with standard values, but also to all the available combination of financial indicators and ratios.

СThe average value of product profitability in the group of companies TOP-10 in 2015 is notably higher than in TOP-100 group and than the industry-average value. At the same time, four companies of the TOP-10 (highlighted with the yellow shading in the Table 1) do not conform to the practical importance.

The revenue volume of the 10 largest companies amounts to 59% of the total revenue of 100 largest companies. It gives evidence to high monopolization rate in this industry. The shares of the companies largest by the revenue volume in 2015 – NAO R-FARM and JSC Nizhpharm amounted to 33% in the total revenue of the TOP-100 group of companies (Figure 2).

All of the TOP-10 companies were given the Prime and High solvency index Globas-i^®, which bears evidence to their ability to meet debt obligations timely and full.

Three companies of the TOP-10 significantly decreased their net profit in 2015 (highlighted with the red shading in the Table 1), considering the fact that revenue volume of all companies increased comparing to the previous period.

In 2014 there were 18 loss-making companies in the TOP-100 group of companies and in 2015 this number decreased to 7, i.e. by a factor of 2,5.

In whole, the indicators of manufacture of pharmaceutical and other products for medicine in volume terms over the 2010 to 2016 period aren’t stable, which is confirmed by the data of the Federal State Statistics Service (Rosstat) (Table 2).

*) In Table 2, the decline in production is highlighted with the red shading, the growth – with the green one.

Manufacture of pharmaceuticals in monetary terms in the corresponding period in whole were growing, having the exceptionally fast pace in 2015 and 2016 (Figure 3).

Enterprises manufacturing pharmaceutical and other products for medicine are distributed in an uneven manner within country’s regions and generally gravitate to the developed industrial centers, having the infrastructure for high-tech manufacture. It is confirmed by the data of the Information and Analytical system Globas-i, according to which 100 companies industry-largest by the revenue volume for 2015 are registered in 35 regions of Russia (Figure 4).

The Federal law №12-FL as of 07.02.2017 was amended the Chapter One of the Civil Code of RF in part of introduction of a special legal form for the Federal Notary Chamber and notary chambers of the RF subjects. The amendments have come into force since February 7, 2017.

Before adoption of these amendments notary chambers were classified by legal form as non-profit organizations, such as associations and unions.

Activity of notary chambers as legal entities is regulated with the Fundamentals of the legislation of the Russian Federation on the notariate, assembling a set of features and differences by the legal status. Notaries and notary chambers are not subsidiary responsible by their liabilities. Versus associations or unions with sole management body, notaries’ philosophy is based upon self-ruling and collegiateness, i.e. the general meeting of members, president and management council control a notary chamber.

At the same time, according to the Federal law №7-FL as of 12.01.1996 “On non-profit organizations”, members of association or union are subsidiary responsible by their liabilities, the amount of which should be provided in the constituent documents.

Under the adopted Federal law, notary chambers, including the Federal Notary Chamber, are out of associations and unions to resolve the contradictions.

According to the adopted amendments, notary chambers are non-profit corporate organizations. Legal state, procedure of establishment and activity are regulated with the legislation on the notariate.

The Federal law also specified a number of definitions: notary chamber is determined as non-profit organization – professional union with compulsory membership; and notary chamber of the RF subject is a professional union with compulsory membership of practicing notaries. The Federal Notary Chamber is their professional union and is based on compulsory membership too.

Currently the documents of notary chambers are bringing to conformity with the adopted amendments.

The Federal Notary Chamber unifies 84 notary chambers of the RF subjects.

According to the Information and Analytical system Globas-i^® 65 notary chambers and over 5800 notaries engaged in private practice are officially registered in Russia.